DailyIQ
|
Sector:HealthcareAll sectors
Last updated3 minutes ago

MTD·Mettler-Toledo International Inc.

$1398.63
+3.38 (+0.24%)
Overnight$1404.50+5.87 (+0.42%)
High
$1,419.10
Open
$1,393.48
Market Cap
28.55B
52W High
$1,525.17
Low
$1,385.67
P. Close
$1,398.63
P/E
31.53
52W Low
$1,023.05
Fwd P/E
26.99
DailyIQ Est.
-
Inst. Ownership
44.9%
Short Interest
3.86%
Technical Score (1D)
64
BUY
News Sentiment
70
BULLISH
Zacks has upgraded Mettler‑Toledo (MTD) to a Buy rating just 2.1 hours ago, citing upward revisions to EPS estimates for the current and next fiscal year. The earnings lift signals management’s confidence in stronger profitability, which should attract short‑term buying interest. This upgrade is likely to lift MTD’s valuation multiple and support a rally in the next 1–10 trading days as investors chase the revised earnings outlook. The positive sentiment may also prompt analysts to revisit their target prices, potentially widening the upside range. Watch for the company’s upcoming earnings release, which will confirm whether the revised estimates materialize and whether any guidance adjustments are made. If earnings miss the new estimates, the Buy upgrade could be questioned and the rally may stall. Conversely, a beat could reinforce the rating and trigger further upside. Keep an eye on any commentary about cost controls or product mix shifts that could underpin the earnings improvement.
Earnings Summary
Mettler‑Toledo International Inc. is a global provider of precision instruments and related services, serving laboratory and industrial customers across the Americas, Europe, and Asia; the company operates within the Healthcare sector and the Diagnostics & Research industry. In the most recent two quarters, the company generated revenue of $1.129 billion in Q4 2025 and $947.13 million in Q1 2026, a decline from the $1.029 billion and $883.74 million reported in Q3 2025 and Q1 2025 respectively, while EPS fell from $13.36 to $8.91, contrasting with the prior quarter’s $10.09 to $11.15 EPS growth; Mettler‑Toledo has consistently beaten analyst estimates in all seven quarters reported, with EPS beats in Q4 2024, Q1 2025, Q2 2025, Q3 2025, Q4 2025, Q1 2026, and Q2 2026. Over the past year, revenue has risen about 8 % YoY from $1.045 billion in Q4 2024 to $1.129 billion in Q4 2025, and EPS has increased roughly 7–13 % YoY, reflecting strong margin expansion and cost control; the company’s consistent earnings beats underscore a robust profitability trajectory despite modest revenue volatility. Recent news reports that Q2 2026 results showed a 4.5 % YoY revenue gain to $1.03 billion and an EPS of $11.46, a 6.3 % beat over consensus, driven by service revenue growth of 9 % and a 7 % organic increase, with China and emerging markets contributing significantly; management also raised full‑year guidance, signaling confidence in sustaining momentum. Investors should watch the upcoming full‑year guidance release for any adjustments to revenue or EPS expectations, monitor the performance of the service business and China strategy, and pay attention to cost‑control initiatives and capital allocation decisions that could influence the company’s long‑term margin profile.

EPS

EstBeatMiss
$8.10$9.59$11.07$12.56$14.05Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$10.81$11.46+6.1%
Q1'26$8.79$8.91+1.4%
Q4'25$12.93$13.36+3.3%
Q3'25$10.66$11.15+4.6%
Q2'25$9.60$10.09+5.1%

Revenue

EstBeatMiss
$920M$979M$1.0B$1.1B$1.2BQ2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$1.0B$1.0B-1.1%
Q1'26$951M$947M-0.4%
Q4'25$1.1B$1.1B+1.3%
Q3'25 - $1.0B -
Q2'25 - $983M -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

MTD Stock Snapshot

MTD is currently trading at $1404.50, giving Mettler-Toledo International Inc. a market cap of 28.55B and a P/E ratio of 31.5. Today's range spans $1385.67–$1419.10, with shares opening at $1393.48 and moving up $5.87 (0.4%) from the prior close. DailyIQ's technical score sits at 64/100 (HOLD) with a news sentiment reading of 70/100.

Over the past year MTD has traded between $1023.05 and $1525.17 - the current price is +37.3% off the 52-week low and -7.9% from the high.

Sector rotation context matters for MTD's HOLD phase (64/100, HOLD): in Healthcare, large-cap names (28.55B market cap) with neutral technicals and bullish sentiment (70/100) are often in a staging area ahead of a rotation trade. The current P/E ratio stands at 31.5. Price: $1404.50 (in the upper portion of its 52-week range in $1023.05–$1525.17). When sector flows resume, names that consolidated cleanly rather than correcting sharply tend to lead the next leg - and MTD's current setup fits that pattern.

In neutral phases, large-cap Healthcare names like MTD are often where sector rotation debates play out quietly, at 28.55B in capitalization, the stock receives incremental allocation from funds reducing mega-cap exposure without the volatility of a small-cap entry. The 64/100 (HOLD) and bullish sentiment (70/100) at $1404.50 (in the upper portion of its 52-week range) describe a stock that is being considered rather than avoided.

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

0+ articles